Tumor‐induced IL‐33 expression appears to promote anti‐melanoma immune responses via interferon (IFN)‐γ‐producing CD8+ T cells and NK cells,90, 91, 92 while exogenous IL‐33 has been found to exert anti‐melanoma effects through the release of eosinophils and dendritic cells (DCs).92, 93, 94. Here, CD8A is linked to neoplasm.